Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT03539549

Public ClinicalTrials.gov record NCT03539549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Study identification

NCT ID
NCT03539549
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
124 participants

Conditions and interventions

Interventions

  • Abicipar pegol Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 24, 2018
Primary completion
Feb 26, 2019
Completion
Feb 26, 2019
Last update posted
Aug 2, 2020

2018 – 2019

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Phoenix Arizona 85016
Retina Associates Southwest, PC Tucson Arizona 85710
Win Retina Arcadia California 91006
Retina Consultants of Orange County Fullerton California 92835
Mark B. Kislinger, MD, Inc. Glendora California 91741
Atlantis Retina Institute (Atlantis Eyecare) Huntington Beach California 92647
N. California Retina Vitreous Associates Medical Group, INC. Mountain View California 94040
California Eye Specialists Medical Group, Inc Pasadena California 91107
Retinal Consultants Medical Group, Inc. Sacramento California 95819
Colorado Retina Associates Golden Colorado 80401
Retina Specialty Institute Pensacola Florida 32503
Retina Vitreous Associates of Florida St. Petersburg Florida 33711
Center for Retina and Macular Disease Winter Haven Florida 33880
Georgia Retina, P.C. Marietta Georgia 30060
Marietta Eye Clinic Marietta Georgia 30060
Gailey Eye Clinic Bloomington Illinois 61704
Raj K. Maturi, MD, PC Indianapolis Indiana 46290
Sabates Eye Center Leawood Kansas 66211
Sierra Eye Associates Reno Nevada 89502
Capital Region Retina, PLLC Albany New York 12206
Ophthalmic Consultants of Long Island Lynbrook New York 11580
Retina Associates of Western New York Rochester New York 14620
Retina Vitreous Surgeons of Central NY, P.C. Syracuse New York 13224
Cincinnati Eye Institute Cincinnati Ohio 45242
Pennsylvania Retina Specialists, P.C. Camp Hill Pennsylvania 17011
Charleston Neuroscience Institute Ladson South Carolina 29456
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Retina Research Institute of Texas Abilene Texas 79606
Texas Retina Associates Arlington Texas 76012
Austin Retina Associates Austin Texas 78705
Texan Eye Austin Texas 78731
Retinal Consultants of Houston Houston Texas 77030
Premiere Retina Specialists Midland Texas 79706
Retinal Consultants of San Antonio San Antonio Texas 78240
Retina Consultants of Houston The Woodlands Texas 77384
Strategic Clinical Research Group, LLC Willow Park Texas 76087
Retina Institute of Virginia Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03539549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2020 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03539549 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →